Salesforce shares trade near $241.85 on October 19, 2026, recovering from a September pullback that followed a fiscal 2030 revenue target well above Wall Street's forecast. CRM's weekly uptrend is intact, and the stock is outpacing both the S&P 500 and the technology sector. The balance of evidence leans positive with high conviction. The breakout math from here is thin, though: the first target is closer than the stop is.
Why it matters
On September 16, 2026, at its Dreamforce conference, CRM issued a fiscal 2030 revenue target of more than $63 billion, against an analyst consensus of $59.2 billion, CNBC reported. That answered the question that had weighed on the stock: whether AI would hollow out the software business. One CNBC piece went as far as declaring the "SaaSpocalypse" over, with a $276 figure attached.
Much of that good news was already in the price. CRM closed at $255.65 on September 15, the day before the target, which marks its recent peak after a 6-month gain of about 33%. It then slid to near $230 after a global outage during Dreamforce and OpenAI's latest move. The market also faced the Federal Reserve's first rate hike in three years, to 3.75%-4%, and AI safety fears, per CNBC. An outage and a rival's announcement look small next to a guidance beat, so the news only partly explains the drop. The stock now sits 5.4% below that peak.
The last five days are a different story. CRM gained 3.4% while the S&P 500 lost 1.4% and the technology sector ETF XLK lost 5.0%. The market was a headwind and the sector was worse, so the stock's 8.4-point lead over XLK is its own. No news item since September 30 explains it.
The argument about CRM is over what the AI shift does to the business. The bullish case rests on Agentforce, whose annual recurring revenue passed $1.5 billion, up more than 240% from a year earlier; the CNBC trader profile cited above puts a figure of $300 on the stock. The bearish case comes from Fortune, which argues that CRM's $50 billion buyback, funded partly by $25 billion in notes, is a debt-driven cycle rebranded as an AI strategy. The move from per-seat to per-agent, consumption and outcome-based pricing also adds uncertainty to revenue. On valuation, 54 analysts rate the stock a buy with a mean price target of $285.68, which sits 15.3% above the current price. The targets run from $165 to $475, so the spread is wide.
What the evidence says
The long-term thesis is intact, and the stock is in a recovery phase inside an uptrend. Price is above both its 10-week and 40-week averages, and the 50-day average at $231.10 sits well above the 200-day at $198.94. The stock is 61.1% above its 52-week low of $150.12 and 9.2% below its high of $266.23. It is still down 8.7% for the year, while the S&P 500 is up 12.5% and XLK up 29.5%. The stock is catching up, not leading yet on that horizon.
For the next two to six weeks the balance of evidence leans positive, and conviction is high at three of four points. The daily trend runs with the weekly uptrend. CRM leads the S&P 500 by 4.8% over 50 days and XLK by 6.5%. The RSI of 64.5 shows momentum without a stretched market.
The strongest case against that reading is participation and distance. Volume is running 66.6% below its 20-day average, though the session is still in progress, so that figure will move. Price is still under $250 resistance and the 52-week high. The breakout math returns only 0.8 to 1. Those gaps are why conviction is not a full four of four. They do not tip the balance, because the trend, relative strength and support structure all point the same way and the volume figure is a partial-day number.
Levels that matter
The structure holds above $231.10, the 50-day average. A move under it would be the first crack, with $225 as a round-number floor beneath. The trend ends below $220.73, a swing zone where the pullback found its footing. The 200-day average at $198.94 and the $200 round number sit much further down.
The breakout level is a daily close above $250 on volume above its 20-day average. From there the first target is the 52-week high at $266.23, with $275 the next round number above it. The stop sits at $228.97, which is the 50-day average minus a quarter of the 14-day average true range. That gives a reward-to-risk of 0.8 to 1, so the math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target far beyond $266.23, or a much tighter stop. Even the $275 level falls well short.
What would change the picture
A weekly close below $220.73 would change the picture, because it would break the swing zone that defines the current uptrend. The non-price fact most likely to do it is evidence in the company's results that Agentforce growth is fading from its 240% pace, or that outcome-based pricing is eroding seat revenue. Either would suggest the guidance that lifted the stock in September was too generous.
What to watch
- Earnings, December 2, 2026: the number that matters is Agentforce annual recurring revenue against the $1.5 billion mark and the 240% growth rate.
- Sector moves first: XLK fell 5.0% in five days, and the rate path after the Fed's hike and the AI safety debate can move CRM before any company news does.
- Volume at $250: a close above that level on above-average volume is the first sign that buyers are back.
- Valuation: at about $241.85 the stock sits 15.3% below the $285.68 mean analyst target, with individual targets from $165 to $475.